Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$194.44 - $217.61 $90,414 - $101,188
465 Added 4.01%
12,061 $2.36 Million
Q2 2023

Jul 19, 2023

BUY
$183.71 - $210.25 $150,458 - $172,194
819 Added 7.6%
11,596 $2.44 Million
Q1 2023

May 03, 2023

BUY
$191.89 - $259.92 $173,084 - $234,447
902 Added 9.13%
10,777 $2.18 Million
Q4 2022

Jan 11, 2023

BUY
$197.11 - $250.07 $74,704 - $94,776
379 Added 3.99%
9,875 $2.15 Million
Q3 2022

Oct 20, 2022

BUY
$182.44 - $250.54 $175,872 - $241,520
964 Added 11.3%
9,496 $1.87 Million
Q2 2022

Jul 13, 2022

BUY
$204.13 - $302.4 $378,252 - $560,347
1,853 Added 27.74%
8,532 $1.83 Million
Q1 2022

Apr 19, 2022

BUY
$255.51 - $362.11 $207,985 - $294,757
814 Added 13.88%
6,679 $1.9 Million
Q4 2021

Jan 20, 2022

BUY
$351.38 - $448.68 $192,556 - $245,876
548 Added 10.31%
5,865 $2.21 Million
Q3 2021

Oct 12, 2021

SELL
$372.64 - $458.3 $212,404 - $261,231
-570 Reduced 9.68%
5,317 $2.19 Million
Q2 2021

Jul 16, 2021

SELL
$294.17 - $371.65 $274,460 - $346,749
-933 Reduced 13.68%
5,887 $2.18 Million
Q1 2021

Apr 15, 2021

BUY
$249.67 - $299.48 $63,665 - $76,367
255 Added 3.88%
6,820 $1.98 Million
Q4 2020

Jan 13, 2021

SELL
$222.0 - $252.62 $20,646 - $23,493
-93 Reduced 1.4%
6,565 $1.64 Million
Q3 2020

Oct 13, 2020

SELL
$175.56 - $226.45 $112,885 - $145,607
-643 Reduced 8.81%
6,658 $1.51 Million
Q2 2020

Jul 21, 2020

SELL
$118.84 - $189.72 $96,260 - $153,673
-810 Reduced 9.99%
7,301 $1.27 Million
Q1 2020

May 07, 2020

BUY
$98.9 - $178.34 $802,177 - $1.45 Million
8,111 New
8,111 $1.02 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.